ETF Managers Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

ETF Managers Group’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,107	Closed	-$26K	–	851
2022 Q2	$26K	Buy	7,107 +323	+5%	+$1.13K	﹤0.01%	732
2022 Q1	$43K	Buy	6,784 +23	+0.3%	+$144	﹤0.01%	665
2021 Q4	$74K	Sell	6,761 -1,007	-13%	-$14K	﹤0.01%	651
2021 Q3	$125K	Buy	7,768 +1,265	+19%	+$22.6K	﹤0.01%	633
2021 Q2	$123K	Sell	6,503 -100	-2%	-$1.92K	﹤0.01%	618
2021 Q1	$92K	Sell	6,603 -2,525	-28%	-$54.9K	﹤0.01%	641
2020 Q4	$256K	Buy	+9,128	New	+$121K	0.01%	566

Other funds holding CDAK

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Ensign Peak Advisors

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return